Search En menu ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages

    Signature(s)

    Amount
    € 30,000,000
    Countries
    Sector(s)
    Germany : € 30,000,000
    Services : € 30,000,000
    Signature date(s)
    9/07/2020 : € 2,500,000
    9/07/2020 : € 2,500,000
    12/12/2016 : € 12,500,000
    12/12/2016 : € 12,500,000
    Link to source

    Summary sheet

    Release date
    16 December 2016
    Status
    Reference
    Signed | 12/12/2016
    20160480
    Project name
    Promoter - financial intermediary
    CURETIS (EGFF)
    CURETIS GMBH
    Proposed EIB finance (Approximate amount)
    Total cost (Approximate amount)
    EUR 30 million
    EUR 50 million
    Location
    Sector(s)
    • Services - Professional, scientific and technical activities
    Description
    Objectives

    The project would support the company's activities in the development of molecular diagnostics tests for severe infectious diseases in hospitalised patients. The project would support the development of novel test panels, e.g. for intra-abdominal infections and sepsis host response as well as urinary tract infection, cardiology-associated infection and extended respiratory panels, as well as future panels on platforms such as the Unyvero platform. In addition, the project would support the necessary clinical trials to obtain the relevant regulatory approvals for market authorisation and reimbursement, and capital expenditure for manufacturing expansion.

    The project falls within the scope of the Societal Challenges Horizon 2020 programme (Health, Demographic Change and Wellbeing), addressing research and development (R&D) within molecular diagnostics. By supporting development of rapid, reliable and accurate diagnostics, this project contributes to the need for improved and cost-effective treatment of hospitalised patients while increasing accuracy.

    Environmental aspects
    Procurement

    The promoter's investments concern research, development and innovation activities as well as production deployment that will be in large part carried out in existing facilities already authorised for similar activities and volumes and that do not require an environmental impact assessment (EIA) according to the relevant EU directives.

    The promoter is a private company not operating in the utilities sector and not having the status of a contracting authority. Thus, it is not covered by EU directives on procurement.

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    scoreboard - EUROPEAN GROWTH FINANCE FACILITY
    Publication Date
    13 Sep 2019
    Document Language
    English
    Main Topic
    lending
    Document Number
    122912044
    Document Focus
    EFSI legal requirements
    Document Type
    Scoreboard
    Project Number
    20170859
    Last update
    19 Aug 2020
    Sector(s)
    Industry
    Publicly available
    Download now

    News & Stories

    General enquiries and comments

    The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities.
    Enquiries and comments concerning the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
    Alternatively, the EIB can be contacted through its external offices.
    Queries regarding details of a specific project, in particular when it is under appraisal by the EIB, should preferably be addressed directly to project promoters.

    Media enquiries

    Media-related enquiries can be addressed to the EIB Press Office. Please also visit our Media information section.

    Complaints mechanism

    Any complaint regarding alleged maladministration can be lodged via the EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.

    Zero tolerance against fraud and corruption

    The EIB has a zero tolerance policy on fraud or corruption. To report allegations of fraud and corruption relating to EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential and handled in line with the EIB investigation procedures and the Anti-Fraud Policy.

    Related publications